BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10523650)

  • 1. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts.
    Reynaud EG; Pelpel K; Guillier M; Leibovitch MP; Leibovitch SA
    Mol Cell Biol; 1999 Nov; 19(11):7621-9. PubMed ID: 10523650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of MyoD by direct binding to p57(Kip2).
    Reynaud EG; Leibovitch MP; Tintignac LA; Pelpel K; Guillier M; Leibovitch SA
    J Biol Chem; 2000 Jun; 275(25):18767-76. PubMed ID: 10764802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.
    Kitzmann M; Vandromme M; Schaeffer V; Carnac G; Labbé JC; Lamb N; Fernandez A
    Mol Cell Biol; 1999 Apr; 19(4):3167-76. PubMed ID: 10082583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
    Joaquin M; Watson RJ
    J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role for the 310 helix region of p57(Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression.
    Hashimoto Y; Kohri K; Kaneko Y; Morisaki H; Kato T; Ikeda K; Nakanishi M
    J Biol Chem; 1998 Jun; 273(26):16544-50. PubMed ID: 9632724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p27(Kip1) in human intestinal cell differentiation.
    Deschênes C; Vézina A; Beaulieu JF; Rivard N
    Gastroenterology; 2001 Feb; 120(2):423-38. PubMed ID: 11159883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells.
    Tintignac LA; Leibovitch MP; Kitzmann M; Fernandez A; Ducommun B; Meijer L; Leibovitch SA
    Exp Cell Res; 2000 Aug; 259(1):300-7. PubMed ID: 10942602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB; Gregory FJ; Stott FJ; Hara E; Peters G
    Mol Cell Biol; 1999 Mar; 19(3):1981-9. PubMed ID: 10022885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo.
    Gómez Lahoz E; Liegeois NJ; Zhang P; Engelman JA; Horner J; Silverman A; Burde R; Roussel MF; Sherr CJ; Elledge SJ; DePinho RA
    Mol Cell Biol; 1999 Jan; 19(1):353-63. PubMed ID: 9858559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression.
    Jiang H; Chou HS; Zhu L
    Mol Cell Biol; 1998 Sep; 18(9):5284-90. PubMed ID: 9710613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
    Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
    Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta1-mediated hypertrophy involves inhibiting pRB phosphorylation by blocking activation of cyclin E kinase.
    Liu B; Preisig P
    Am J Physiol; 1999 Aug; 277(2):F186-94. PubMed ID: 10444572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
    Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.
    Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z
    Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.
    Figliola R; Busanello A; Vaccarello G; Maione R
    J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation.
    Xu X; Nakano T; Wick S; Dubay M; Brizuela L
    Biochemistry; 1999 Jul; 38(27):8713-22. PubMed ID: 10393546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of nuclear transport and degradation of the Xenopus cyclin-dependent kinase inhibitor, p27Xic1.
    Chuang LC; Yew PR
    J Biol Chem; 2001 Jan; 276(2):1610-7. PubMed ID: 11044455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.